Learning outcomes
By the end of this lesson you should be able to: name the five major lipoprotein classes and say where each is made and where each goes; explain how triacylglycerol versus cholesterol content sets the density of a particle; describe the two pathways — the exogenous from the gut and the endogenous from the liver — and the tissue to which each delivers; explain how a chylomicron remnant is cleared and why the pathway matters clinically; state the role of apolipoproteins B-48 and B-100, the E receptor and the LDL receptor; and name the enzyme that unloads a lipoprotein particle and the drug that inhibits its action.
Prerequisites
Lesson 7 (lipids) for the cholesterol, the phospholipid and the triacylglycerol cargo, and Lesson 8 for the surface of the particle, which is a monolayer rather than a bilayer.
The big idea
One sentence sets up the whole topic. Blood is water, so it cannot carry fat; it therefore carries fat in droplets, and the droplet is the lipoprotein. The physics of the droplet decides its density: dense particles are small and rich in protein, while light particles are big and rich in lipid. Learn the density classes and you have the transport system.
| Class | Density | Triacylglycerol | Cholesterol | Apolipoprotein | Made by | Goes to |
|---|---|---|---|---|---|---|
| Chylomicron | Lowest | Highest | Low | B-48, C-II, E | The gut | Muscle and adipose tissue |
| Chylomicron remnant | Intermediate | Low | High | E only | From the chylomicron | The liver |
| VLDL | Low | High | Low | B-100, E | The liver | Adipose and muscle tissue |
| IDL | Intermediate | Moderate | Moderate | B-100, E | From VLDL | The liver or the tissues |
| LDL | High | Low | Highest | B-100 only | From IDL | Nearly every tissue |
| HDL | Highest | Low | High | A-I, A-II | The liver and the gut | The liver, in reverse cholesterol transport |
NoteThe less dense a particle, the more triacylglycerol it holds and the bigger it is. The densest, HDL, is the smallest and the most protein rich; the chylomicron is the largest and the least dense. That is the whole basis of the clinical classification.
Worked example: the exogenous pathway
Dietary fat is absorbed and reassembled into triacylglycerol inside the mucosal cells of the small bowel, and is packaged into chylomicrons, which are secreted into the lymph rather than into the blood. Follow them to the tissues.
| Step | What happens | Consequence |
|---|---|---|
| Assembly | The enterocyte reassembles absorbed fat into triacylglycerol and coats it with a B-48 apolipoprotein | A chylomicron is formed, the largest and least dense of the lipoproteins |
| Release | The particle enters the lacteal, the lymphatic of the villus, and reaches the blood via the thoracic duct | This is why a milky lymph and a milky plasma appear after a fatty meal |
| Unloading | Lipoprotein lipase on the capillary wall hydrolyses the triacylglycerol, and the free fatty acids enter muscle or adipose tissue | The particle shrinks and becomes denser, so it is now a remnant |
| Clearance | The remnant, coated only with apolipoprotein E, is taken up by the liver through the E receptor | The fat journey ends and the cholesterol reaches the organ that processes it |
NoteThe B-48 and B-100 distinction is the key to the whole classification: B-48 is made by the gut and B-100 by the liver. The particle is named by where its single apolipoprotein was made, and each has only one, because each is one assembly.
A patient with a defective B-100 cannot unload the endogenous triacylglycerol. Which lipoprotein accumulates and which tissue fails first?
Worked example: the endogenous pathway
The liver handles the fat that the diet did not, and the pathway it uses is the circulating one that LDL comes from.
| Step | What happens |
|---|---|
| Secretion | The liver secretes VLDL, a particle with a B-100 apolipoprotein and a high triacylglycerol content |
| Remodelling | In the capillaries, lipoprotein lipase unloads the triacylglycerol, and the particle becomes smaller, denser and cholesterol richer, so it is now IDL |
| Fate one | The IDL is taken up by the liver, which completes the cycle |
| Fate two | The IDL loses its E apolipoprotein and becomes LDL, which circulates for days and delivers cholesterol to the tissues |
| End | LDL is cleared by the LDL receptor, which binds the B-100 apolipoprotein — the receptor whose absence causes familial hypercholesterolaemia |
HDL and reverse cholesterol transport
The HDL particle is built in the liver and the gut as a small disc, and it scavenges cholesterol from extrahepatic tissues, including from the macrophages of an artery wall where it has done damage. It esterifies the cholesterol with lecithin cholesterol acyltransferase, which lets the particle hold a hydrophobic core, and it returns the cholesteryl ester to the liver. That reverse direction is why HDL is called the protective lipoprotein, and why the ratio of total cholesterol to HDL cholesterol is a better predictor of coronary risk than either alone.
NoteThe macrophages of an artery wall make the HDL pathway look like a garbage collection, and the reason a low HDL is dangerous is that the garbage stops being collected: cholesterol accumulates in the foam cell, which becomes the fatty streak and then the atherosclerotic plaque.
Clinical relevance
| Disorder | Mechanism | Cardiovascular risk |
|---|---|---|
| Familial hypercholesterolaemia | The LDL receptor is absent or defective, so LDL cannot be cleared | Very high LDL and very early coronary disease |
| Familial defective apolipoprotein B-100 | B-100 cannot bind the receptor, so the LDL is not cleared | Similar to the receptor defect |
| Lipoprotein lipase deficiency | The chylomicrons cannot unload, so they accumulate | Eruptive xanthomas, pancreatitis, and little coronary disease |
| Low HDL | The reverse cholesterol transport particle is deficient | A risk factor that is partly inherited and partly lifestyle |
| Tangier disease | A rare defect of the apolipoprotein A-I synthesis of HDL | Orange tonsils, neuropathy and a very low HDL cholesterol |
NoteThe statins lower cholesterol by blocking the committed enzyme of synthesis in the liver, and the liver compensates by expressing more LDL receptors on its surface, which pulls LDL out of the blood. The mechanism is therefore receptor dependent, which is why a patient with no LDL receptor cannot be helped by a statin alone.
Common mistakes
Watch outSaying HDL is a molecule. It is a particle, with a surface of phospholipid and protein and a core of cholesteryl ester, and its size and density change as it works.
Watch outSaying the chylomicron is made in the liver. It is made in the enterocyte of the gut and reaches the blood through the lymph; the liver makes VLDL.
Watch outSaying the chylomicron remnant goes to the tissues. It goes to the liver, cleared by the E receptor, which is the end of the exogenous pathway.
Check your understanding
Why does a VLDL particle become an LDL particle, and what does it gain or lose?
How does reverse cholesterol transport protect the artery wall?
Which lipoprotein is elevated in lipoprotein lipase deficiency, and in which disorder is the LDL receptor absent?
Multiple choice
Which lipoprotein is produced by the intestine and carries dietary triacylglycerol?
Which lipoprotein particle is the richest in cholesterol?
Which apolipoprotein is carried only by the lipoproteins made in the intestine?
Which receptor clears the chylomicron remnant from the circulation?
What is the mechanism by which the statins lower plasma LDL cholesterol?
Which statement about reverse cholesterol transport is correct?
Summary and next
Blood is water, so blood carries fat in particles, and a lipoprotein is a drop of phospholipid with a hydrophobic core. The gut makes the triacylglycerol rich chylomicron that unloads its fat in the capillaries and leaves a cholesterol rich remnant for the liver; the liver makes VLDL, which is remodelled into the cholesterol rich LDL that delivers to the whole body and is cleared by the LDL receptor; and the liver and gut also make HDL, which collects the cholesterol that the tissues and the artery wall have too much of and carries it back in reverse transport.
Next: the last of the lipid-derived messengers. You will meet the prostaglandins and the leukotrienes, and the steroid hormones, all of which are made from the very lipids whose transport you have just learned.